Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 17;14(9):1171.
doi: 10.3390/life14091171.

Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort

Lynn Anna Barbara Zweifel  1 , Jens Julian Storp  1 , Friederike Elisabeth Vietmeier  1 , Moritz Fabian Danzer  2 , Ralph-Laurent Merté  1 , Nicole Eter  1 , Viktoria Constanze Brücher  1
Affiliations

Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort

Lynn Anna Barbara Zweifel et al. Life (Basel). .

Abstract

To compare success rates of trabeculectomy (TE) and Preserflo MicroShunt (PMS) in heterogenous glaucoma cohorts with regards to different pre- and postoperative therapeutic regimens. Data of 187 glaucoma patients who either received TE (73 eyes) or PMS implantation (114 eyes) between January 2018 and December 2022 were retrospectively evaluated. Surgical success and failure rates were analyzed within six months of follow-up. Intraocular pressure (IOP) development over the course of follow-up was compared between both groups. Tertiary outcome measures were best-corrected visual acuity (BCVA), number and type of medications, frequency of postoperative complications and revision surgeries. Outcome measures underwent additional assessment based on subgroup categorizations, and failure time hazard ratios were computed. The success rates were comparable between both procedures (TE: 54.1%, PMS: 60.0%; p = 0.17). Both procedures showed significant IOP reduction (p < 0.01); however, overall IOP reduction was greater in the TE group than in the PMS group (TE: Reduction by 12 mmHg (188.9%), PMS: Reduction by 7 mmHg (51.3%); p = 0.01). The number of topical medications decreased significantly in both groups over the course of follow-up (TE: 4 to 0, PMS: 3 to 0; p < 0.01). While the number of complications and revision surgeries were similar in both groups, the time interval until the first revision surgery within the TE group was significantly shorter (TE: 13.5 d, PMS: 163 d; p = 0.01) than within the PMS group. No difference could be detected between TE and PMS with regard to the follow-up regimen. In particular, there was no significant difference in the need for 5-floururacil injections postoperatively (p = 0.29). Less invasive glaucoma surgery with the PMS appeared comparable to the TE within a heterogenous glaucoma cohort with regards to IOP development and freedom from medication.

Keywords: IOP; LIGS; MIGS; PEX; POAG; TE; glaucoma; microinvasive glaucoma surgery; real-world.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Graphical representation of IOP development throughout follow-up within the TE (dark blue) and PMS groups (light blue). Note that time intervals are not to scale.
See this image and copyright information in PMC

References

    1. Musch D.C., Gillespie B.W., Niziol L.M., Lichter P.R., Varma R., CIGTS Study Group Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118:1766–1773. doi: 10.1016/j.ophtha.2011.01.047. - DOI - PMC - PubMed
    1. Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: A review. JAMA. 2014;311:1901–1911. doi: 10.1001/jama.2014.3192. - DOI - PMC - PubMed
    1. Arora K.S., Robin A.L., Corcoran K.J., Corcoran S.L., Ramulu P.Y. Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012. Ophthalmology. 2015;122:1615–1624. doi: 10.1016/j.ophtha.2015.04.015. - DOI - PubMed
    1. Vinod K., Gedde S.J., Feuer W.J., Panarelli J.F., Chang T.C., Chen P.P., Parrish R.K., 2nd Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society. J. Glaucoma. 2017;26:687–693. doi: 10.1097/IJG.0000000000000720. - DOI - PMC - PubMed
    1. Saheb H., Ahmed I.I.K. Micro-invasive glaucoma surgery: Current perspectives and future directions. Curr. Opin. Ophthalmol. 2012;23:96–104. doi: 10.1097/ICU.0b013e32834ff1e7. - DOI - PubMed

LinkOut - more resources